Delivery Order SPE2DB22D1106-SPE2DB24FFHP2

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 100 mg tablets. The contract has a ceiling value of $2,544.90 and a completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 150 MG TABLET 60S. The contract has a ceiling value of $1,792.52 and a completion date of September 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 200 MG TABLET 60S. The award has a ceiling value of $6,053.44 and an ultimate completion date of August 19, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The order is for 4,566,088 units of the pharmaceutical product NUCYNTA ER 150 MG TABLET 60S, with a ceiling value of $1,474.21. The delivery order is a firm fixed-price contract with an ultimate completion date of October 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of NUCYNTA ER 100 mg tablets, with a total ceiling value of $1,388.98 and a period of performance through October 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements indicated. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order (Contract Number SPE2DB22D1106|SPE2DB25FDMA1) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,502.56 firm fixed-price contract is for the delivery of NUCYNTA ER 50 MG TABLET 60S, a prescription medication. The contract is not designated as a set-aside and has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nucynta ER 200 mg tablets. The fixed-price contract has a ceiling value of $2,411.52 and a period of performance through June 6, 2025. The contract is not set-aside and is an open competition award. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 150 MG Tablets. The contract has a ceiling value of $7,206.44 and is set to expire on September 18, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 200 MG TABLET 60S. The $10,839.70 contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 250 MG TABLET 60S. The contract has a ceiling value of $8,370.02 and a completion date of June 20, 2024. It is a firm fixed-price contract, and there is no set-aside designation noted. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFHP2
    Delivery Order

This is a delivery order (SPE2DB22D1106|SPE2DB24FFHP2) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA ER 150 MG TABLET 60S. The contract has a ceiling value of $11,047.06 and is a firm fixed-price delivery order, with an ultimate completion date of August 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals, from AmerisourceBergen to support military treatment programs and facilities worldwide. There is no set-aside designation for this specific award.

Generated 11/19/24, 9:29 AM